{
  "abstract": "The announcement of the UK rollout of the meningitis vaccine 4CMenB against gonorrhoea to those at high risk, focused on men who have sex with men (MSM), makes the use of vaccines against gonorrhoea clinically pertinent.12",
  "authors": [
    {
      "affiliations": [
        "Oxfordshire Sexual Health Service, Oxford University Hospitals NHS Foundation Trust, UK"
      ],
      "name": "Nell Freeman-Romilly"
    },
    {
      "affiliations": [
        "Oxfordshire Sexual Health Service, Oxford University Hospitals NHS Foundation Trust, UK"
      ],
      "name": "Emily Lord"
    },
    {
      "affiliations": [
        "Oxfordshire Sexual Health Service, Oxford University Hospitals NHS Foundation Trust, UK"
      ],
      "name": "Katrina Pollock"
    }
  ],
  "title": "Gonorrhoea vaccination strategies should take into account all at risk and the potential for severe sequelae in women",
  "uid": "b2d53015-f4de-5db8-8d02-1b20c8a0517c"
}